The ophthalmologist and the global impact of the AIDS epidemic LV Edward Jackson Memorial Lecture (Q33827318)

29 July 2017

1 reference

title

The ophthalmologist and the global impact of the AIDS epidemic LV Edward Jackson Memorial Lecture (English)

1 reference

29 July 2017

R Belfort

1

1 reference

29 July 2017

language of work or name

English

0 references

publication date

1 January 2000

1 reference

American Journal of Ophthalmology

29 July 2017

published in

1 reference

29 July 2017

volume

129

1 reference

29 July 2017

issue

1

1 reference

29 July 2017

page(s)

1-8

1 reference

Honoring the history of the Edward Jackson Memorial Lecture. The L Edward Jackson Memorial Lecture. Part 1.

29 July 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9394%2899%2900428-6

Edward Jackson in 1896: a man and his specialty at a crossroads. LIII Edward Jackson Memorial Lecture: Part 1.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9394%2899%2900428-6

Ocular manifestations of HIV infection

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9394%2899%2900428-6

Ocular Disorders Associated with a new Severe Acquired Cellular Immunodeficiency Syndrome

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9394%2899%2900428-6

Frequent Detection and Isolation of Cytopathic Retroviruses (HTLV-III) from Patients with AIDS and at Risk for AIDS

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9394%2899%2900428-6

The safety and efficacy of zidovudine (AZT) in the treatment of subjects with mildly symptomatic human immunodeficiency virus type 1 (HIV) infection. A double-blind, placebo-controlled trial. The AIDS Clinical Trials Group

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9394%2899%2900428-6

Viral-load tests provide valuable answers

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9394%2899%2900428-6

HIV/AIDS. Protease inhibitors vindicated

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9394%2899%2900428-6

Declining morbidity and mortality among patients with advanced human immunodeficiency virus infection. HIV Outpatient Study Investigators

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9394%2899%2900428-6

Treatment with indinavir, zidovudine, and lamivudine in adults with human immunodeficiency virus infection and prior antiretroviral therapy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9394%2899%2900428-6

A controlled trial of two nucleoside analogues plus indinavir in persons with human immunodeficiency virus infection and CD4 cell counts of 200 per cubic millimeter or less. AIDS Clinical Trials Group 320 Study Team

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9394%2899%2900428-6

Antiretroviral therapy for HIV infection: promises and problems

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9394%2899%2900428-6

Recovery of the immune system with antiretroviral therapy: the end of opportunism?

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9394%2899%2900428-6

Long-lasting remission of cytomegalovirus retinitis without maintenance therapy in human immunodeficiency virus-infected patients.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9394%2899%2900428-6

Biphasic kinetics of peripheral blood T cells after triple combination therapy in HIV-1 infection: a composite of redistribution and proliferation.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9394%2899%2900428-6

How drug resistance arises.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9394%2899%2900428-6

Progress and problems in the fight against AIDS

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9394%2899%2900428-6

"Buffalo hump" in men with HIV-1 infection.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9394%2899%2900428-6

Pathogenesis of HIV-1-protease inhibitor-associated peripheral lipodystrophy, hyperlipidaemia, and insulin resistance

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9394%2899%2900428-6

Opportunistic infections of the eye in immunocompromised patients

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9394%2899%2900428-6

HIV and AIDS and the eye in developing countries: a review

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9394%2899%2900428-6

Ocular complications of Stevens-Johnson syndrome and toxic epidermal necrolysis in patients with AIDS.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9394%2899%2900428-6

Tuberculosis in patients with human immunodeficiency virus infection

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9394%2899%2900428-6

Spectrum of disease in Africans with AIDS in London.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9394%2899%2900428-6

Risk of tuberculosis in patients with HIV-I and HIV-II infections in Abidjan, Ivory Coast

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9394%2899%2900428-6

Systemic viral infections and their retinal and choroidal manifestations

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9394%2899%2900428-6

Squamous cell carcinoma of the conjunctiva in a patient with the acquired immunodeficiency syndrome

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9394%2899%2900428-6

Conjunctival squamous-cell carcinoma associated with HIV infection in Kampala, Uganda

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9394%2899%2900428-6

Treatment with corticosteroids--a risk factor for the development of clinical cytomegalovirus disease in AIDS

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9394%2899%2900428-6

Immune recovery vitritis associated with inactive cytomegalovirus retinitis: a new syndrome

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9394%2899%2900428-6

Guidelines for the treatment of cytomegalovirus diseases in patients with AIDS in the era of potent antiretroviral therapy: recommendations of an international panel. International AIDS Society-USA.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9394%2899%2900428-6

HIV 1998: the global picture

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9394%2899%2900428-6

Promising new treatments for cytomegalovirus retinitis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9394%2899%2900428-6

Use of the ganciclovir implant in the treatment of recurrent cytomegalovirus retinitis.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9394%2899%2900428-6

Ocular manifestations of the human immunodeficiency virus and the acquired immunodeficiency syndrome in developing countries

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9394%2899%2900428-6

Ocular toxoplasmosis in human immunodeficiency virus-infected patients.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9394%2899%2900428-6

Transient vitreous inflammatory reactions associated with combination antiretroviral therapy in patients with AIDS and cytomegalovirus retinitis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9394%2899%2900428-6

Vitreomacular traction syndrome following highly active antiretroviral therapy in AIDS patients with cytomegalovirus retinitis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9394%2899%2900428-6

Cystoid macular edema associated with cytomegalovirus retinitis in patients with the acquired immunodeficiency syndrome

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9394%2899%2900428-6

Russia: sex, drugs, and AIDS and MSF.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9394%2899%2900428-6

Condom availability in New York City public high schools: relationships to condom use and sexual behavior.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9394%2899%2900428-6

The care of HIV-infected adults in the United States. HIV Cost and Services Utilization Study Consortium.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9394%2899%2900428-6

Impact of HIV infection and AIDS on prevalence of type 2 diabetes in South Africa in 2010.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9394%2899%2900428-6

Deciding life and death in the courtroom: debate and clarification

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9394%2899%2900428-6

7 January 2021

Improving HIV therapy.

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9394%2899%2900428-6

7 January 2021

Retinal Toxicity in Human Immunodeficiency Virus–infected Children Treated With 2′,3′-Dideoxyinosine

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9394%2899%2900428-6

7 January 2021

HIV vaccines: prospects and challenges

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9394%2899%2900428-6

7 January 2021

Preventing HIV infection

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9394%2899%2900428-6

7 January 2021

10.1016/S0002-9394(99)00428-6

Identifiers

DOI

1 reference

29 July 2017

1 reference